Advertisement

Journal of Clinical Monitoring and Computing

, Volume 31, Issue 1, pp 227–230 | Cite as

Assessing the effect of preoperative levosimendan on renal function in patients with right ventricular dysfunction

  • Jose L. Guerrero OrriachEmail author
  • M. Galán Ortega
  • A. Ramírez Fernandez
  • D. Ariza Villanueva
  • A. Florez Vela
  • I. Moreno Cortés
  • M. Rubio Navarro
  • J. Cruz Mañas
Brief Communication

Abstract

The Acute Kidney Injury Network (AKIN) classification considers SCr values, urea and urine output in order to improve timely diagnose ARF and improve patient prognosis by early treatment. Preoperative levosimendan is a new way for cardiac and kidney protection, we try to evaluate this drug in fifteen patients comparing values of AKIN scale parameters pre and post cardiac surgery in patients with right ventricle dysfunction.

Keywords

Levosimendan Acute renal failure Preoperative Kidney AKIN scale 

Notes

Compliance with ethical standards

Conflict of interest

Authors do not have a financial relationship with the organization that sponsored the research. The authors declare that they have no conflict of interest.

References

  1. 1.
    Severi L, Lappa A, Landoni G, Di Pirro L, Luzzi SJ, Caravetta P, et al. Levosimendan versus intra-aortic balloon pump in high-risk cardiac surgery patients. J Cardiothorac Vasc Anesth. 2011;25:632–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Lucioni C, D´Ambrosi A, Mazzi S. Economic evaluation of levosimendan versus dobutamine for the treatment of acute heart failure in Italy. Adv Ther. 2012;29:1037–50.CrossRefPubMedGoogle Scholar
  3. 3.
    Landoni G, Augoustides JG, Guarracino F, Santini F, Ponschab M, Pasero D, et al. Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. Acta Anaesthesiol Scand. 2011;55:259–66.CrossRefPubMedGoogle Scholar
  4. 4.
    Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Skhiri M, Hunt S, Denault Y, Haddad F. Evidence-based management of right heart failure: a systematic review of an empiric field. Rev Esp Cardiol. 2010;63:451–71.CrossRefPubMedGoogle Scholar
  6. 6.
    Haji S, Movahed A. Right ventricular infarction: diagnosis and treatment. Clin Cardiol. 2000;23:473–82.CrossRefPubMedGoogle Scholar
  7. 7.
    Leppikangas H, Järvelä K, Sisto T, Maaranen P, Virtanen M, Lehto P, et al. Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery. Br J Anaesth. 2011;106:298–304.CrossRefPubMedGoogle Scholar
  8. 8.
    Levin R, Degrange M, Del Mazo C, Tanus E, Porcile R. Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Exp Clin Cardiol. 2012;17:125–30.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Levin RL, Degrange MA, Porcile R, Salvagio F, Blanco N, Botbol AL, et al. The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome. Rev Esp Cardiol. 2008;61:471–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Ochi H, Izumi S, Murakami R, Shimada T, Morioka S, Moriyama K. Superior vena cava flow and tricuspid anular motion after cardioversion of atrial fibrillation, and role of right atrial relaxation on systolic venous return. Am J Cardiol. 1991;68(13):1335–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Haddad F, Fuh E, Peterson T, Skhiri M, Kudelko KT, De Perez Jesus V, et al. Incidence, correlates and consequences of acute kidney injury in patients with pulmonary arterial hypertension hospitalized with acute right-side heart failure. J Card Fail. 2011;17:533–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Fedele F, Bruno N, Brasolin B, Caira C, D´Ambrosi A, Mancone M. Levosimendan improves renal function in acute decompensated heart failure: posible underlying mechanisms. Eur J Heart Fail. 2014;16:281–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Baysal A, Yanartas M, Dogukan M, Gundogus N, Kocak T, Koksal C. Levosimendan improves renal outcome in cardiac surgery: a randomized trial. J Cardiothorac Vasc Anesth. 2014;28(3):586–94.CrossRefPubMedGoogle Scholar
  14. 14.
    Bragadottir G, Redfors B, Ricksten SE. Effects of levosimendan on glomerular filtration rate, renal blood flow and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study. Crit Care Med. 2013;41:2328–35.CrossRefPubMedGoogle Scholar
  15. 15.
    Guerrero-Oriach JL, Navarro-Arce I, Iglesias P, Galán-Ortega M, Rubio-Navarro M, Mañas JC. Preoperative levosimendan for right ventricular dysfunction before heart valve replacement surgery. Rev Esp Cardiol. 2013;66:999–1000.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2016

Authors and Affiliations

  • Jose L. Guerrero Orriach
    • 1
    Email author
  • M. Galán Ortega
    • 1
  • A. Ramírez Fernandez
    • 1
  • D. Ariza Villanueva
    • 1
  • A. Florez Vela
    • 1
  • I. Moreno Cortés
    • 1
  • M. Rubio Navarro
    • 1
  • J. Cruz Mañas
    • 1
  1. 1.Department of AnaesthesiaHospital Virgen de la VictoriaMálagaSpain

Personalised recommendations